[Long-term toxicity of benorylate]

Area of Science:

• Pharmacology
• Toxicology
• Rheumatology

Context:

• Rheumatoid arthritis (RA) management often requires long-term medication.
• Assessing the safety profile of therapeutic agents is crucial for patient care.
• Benorilate is a medication used for RA treatment.

Purpose:

• To evaluate the potential toxic effects of benorilate on key organs.
• To assess the safety of benorilate in patients with rheumatoid arthritis.
• To monitor bone marrow, liver, and kidney function during benorilate therapy.

Summary:

• A long-term study monitored 33 rheumatoid arthritis patients receiving therapeutic doses of benorilate.
• Hematological, renal, and hepatic function tests were conducted regularly.
• No significant toxicity was observed in bone marrow, liver, or kidneys.

Impact:

• Benorilate demonstrates a favorable safety profile for rheumatoid arthritis treatment.
• The drug's composition and hydrolysis contribute to its tolerability and efficacy.
• Findings support the use of benorilate in managing rheumatoid arthritis with minimal organ toxicity.